Search alternatives:
teer decrease » greater decrease (Expand Search)
men decrease » nn decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 men » 10 men (Expand Search), 42 men (Expand Search)
teer decrease » greater decrease (Expand Search)
men decrease » nn decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 men » 10 men (Expand Search), 42 men (Expand Search)
-
1721
Changes in the prevalence of reflux esophagitis (men, women, and total) from 2010 to 2019 in Japan.
Published 2022Subjects: -
1722
-
1723
-
1724
-
1725
-
1726
Bortezomib in combination with the PLK1 inhibitor BI 2536 induces a significant downregulation of the total levels and phosphorylation of Bcr-Abl, a decrease of downstream phosphorylated STAT5 and a caspase-dependent cell death in TKIs-resistant and –sensitive K562 cell lines.
Published 2013“…K562 and K562-R cells were treated with 9nM bortezomib and 8nM BI 2536 for 60h, followed by the detection of Bcr-Abl and phosphorylated STAT5. The combined treatment resulted in a marked decrease of the total levels of Bcr-Abl, which correlates with a decrease in the phosphorylation of the downstream STAT5 protein, in both K562 and K562-R cells. β-Actin was used as an internal loading control. …”
-
1727
-
1728
-
1729
-
1730
-
1731
Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF
Published 2021“…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”
-
1732
Image1_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF
Published 2021“…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”
-
1733
-
1734
-
1735
-
1736
-
1737
-
1738
-
1739
-
1740